Top News
AC Immune Announces Important Clinical Milestones for ACI-24 Vaccine in Alzheimer's Disease and Down Syndrome
SBA Member, 20.08.2018
MetrioPharm Achieves 50% of Target Patients Randomized in MP1032 Phase II Clinical Trial
SBA Member, 14.08.2018
Novartis appoints Dr. Klaus Moosmayer as Chief Ethics Risk and Compliance Officer
SBA Member, 14.08.2018
Basilea reports half-year financial results reflecting strong in-market product sales growth in addition to progress and expansion of the R&D pipeline
SBA Member, 14.08.2018
BC Platforms and Negen Announce Partnership for Early Risk Assessment of Common Diseases
SBA Member, 13.08.2018
ObsEva SA to Participate in Wedbush PacGrow Healthcare Conference August 14-15, 2018
SBA Member, 13.08.2018
Therachon Raises $60 Million Mezzanine Financing to Advance Lead Program in Achondroplasia and to Expand Rare Disease Pipeline
SBA Member, 13.08.2018
Basilea starts clinical phase 3 study with antibiotic ceftobiprole in Staphylococcus aureus bacteremia
SBA Member, 09.08.2018
Partners
Supported by:
